Acute effects of a surgical menopause on serum concentrations of lipoprotein(a)

Climacteric

Volumn 1, Issue 1, 1998, Pages 33-41

  Cheung, L P ^a   Pang, M W ^a   Lam, C W K ^a   Tomlinson, B ^a   Chung, T K H ^a   Haines, C J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Lipids; Lipoprotein(a); Surgical menopause

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; EARLY MENOPAUSE; FEMALE; HUMAN; HYSTERECTOMY; MIDDLE AGED; OVARIECTOMY;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; HYSTERECTOMY; LIPOPROTEIN(A); MENOPAUSE, PREMATURE; MIDDLE AGED; OVARIECTOMY; TRIGLYCERIDES;

EID: 0032023888     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.3109/13697139809080679     Document Type: Article

References (30)

1. Gensini GF, Micheli S, Prisco D, et al. Menopause and risk of cardiovascular disease. Thromb Res 1996;84:1-19
2. Hajjar KA, Gavish D, Breslow JL, et al. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (London) 1989;339:303-5
3. Miles LA, Fless GM, Levin EG, et al. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature (London) 1989;339:301-3
4. Dahlen GH, Guyton JR, Attar M, et al. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65
5. Dahlen GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111-26
6. Schreiner PJ, Chambless LE, Brown SA, et al. Lipoprotein(a) as a correlate of stroke and transient ischaemic attack prevalence in a biracial cohort: the ARIC study. Atherosclerosis Risk in Communities. Ann Epidemiol 1994;4:351-9
7. Masao N, Yukito S, Tomiko N. Lipoprotein(a) and ischaemic cerebrovascular disease in young adults. Stroke 1994;25:74-8
8. Chee KJ, Ryu WS, Kwak JW, et al. Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and oestrogen replacement therapy. Arch Intern Med 1996; 156:500-4
9. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation 1993;87:1135-41
10. De Pergola G, Giorgino F, Cospite MR. Relation between sex hormones and serum lipoprotein and lipoprotein(a) concentrations in premenopausal obese women. Arterioscler Thromb 1993;13: 675-9
11. Brown SA, Hutchison R, Morrisett J, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1139-58
12. Slunga L, Asplund K, Johnson O, et al. Lipoprotein(a) in a randomly selected 25-64 year old population: the Northern Sweden Monica Study. J Clin Epidemiol 1993;46:617-24
13. Soma MR, Meschia M, Bruschi F, et al. Hormonal agents used in lowering lipoprotein(a). Chem Phys Lipids 1994;67-68:345-50
14. Haines C, Chung T, Chang A, et al. Effect of oral estradiol on Lp(a) and other lipoproteins in post-menopausal women. Arch Intern Med 1996; 156:866-72
15. Soma MR, Osnago-gadda I, Paoletti R, et al. The lowering of lipoprotein(a) induced by estrogen plus progesterone replacement therapy in post-menopausal women. Arch Intern Med 1993;153: 1462-7
16. Rozenbery S, Kroll M, Pastijn A, et al. Osteoporosis prevention and treatment with sex hormone replacement therapy. Clin Rheumatol 1995;14:14-17
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL cholesterol in plasma without use of the preparation ultracentrifuge. Clin Chem 1972;18:499-502
18. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women: assessment and management. Eur Heart J 1996;17:2-8
19. Maeda S, Abe A, Seishima M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1988;78:145-50
20. Magnani B, Massone PPB, Meriggi F. The variation of serum lipoprotein(a) during surgical operations. Clin Chim Acta 1992;212:149-51
21. Ledue TB, Neveux LM, Palomaki GE. The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. Clin Chim Acta 1993;223:73-82
22. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993;22:933-40
23. Shaukat N, Ashraf SS, Mackness MI, et al. A prospective study of serum lipoproteins after coronary bypass surgery. Q J Med 1994;87:539-45
24. Kazuyuki F, Koji K, Kenji H, et al. Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study. Maturitas 1995;22: 193-7
25. Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-age healthy women. Arch Intern Med 1994;154:2349-55
26. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas 1990;12:321-31
27. Anthomy MS, Clarkson TB, Hughes CI Jr, et al. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkey. J Nutr 1996; 126:43-50
28. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996; 87:897-904
29. Kao PC, P'eng FK. How to reduce the risk factors of osteoporosis in Asia. Chung Hua I Hsueh Tsa Chih 1995;55:209-13
30. Haines CJ, Chung TKH, Leung DH. A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women. Maturitas 1994;18:175-81